Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8794187 | Ophthalmology | 2018 | 16 Pages |
Abstract
The evidence reviewed supports DMEK as a safe and effective treatment for endothelial failure. With respect to visual recovery time, visual outcomes, and rejection rates, DMEK seems to be superior to DSEK and to induce less refractive error with similar surgical risks and EC loss compared with DSEK. The rate of air injection and repeat keratoplasty were similar in DMEK and DSEK after the learning curve for DMEK.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Sophie X. MD, W. Barry MD, Kristin M. MD, Anthony N. MD, Jennifer Y. MD, Joanne F. MD, Mitchell P. MD, Roni M. MD,